Hörmann A - Search Results

1

Automated production of [⁶⁸Ga]Ga-DOTA-exendin-4 via fractionated radionuclide generator elution on a cassette based synthesis module.

Kraihammer M, von Guggenberg E, Hörmann AA, Gabriel M, Decristoforo C. Kraihammer M, et al. Among authors: hormann aa. Nucl Med Biol. 2023 Sep-Oct;124-125:108381. doi: 10.1016/j.nucmedbio.2023.108381. Epub 2023 Aug 18. Nucl Med Biol. 2023. PMID: 37634398

2

Precision RNAi using synthetic shRNAmir target sites.

Hoffmann T, Hörmann A, Corcokovic M, Zmajkovic J, Hinterndorfer M, Salkanovic J, Spreitzer F, Köferle A, Gitschtaler K, Popa A, Oberndorfer S, Andersch F, Schaefer M, Fellner M, Budano N, Ruppert JG, Chetta P, Wurm M, Zuber J, Neumüller RA. Hoffmann T, et al. Among authors: hormann a. Elife. 2023 Aug 8;12:RP84792. doi: 10.7554/eLife.84792. Elife. 2023. PMID: 37552050 Free PMC article.

3

High unimer concentration and asymmetric bilayer observed in small unilamellar vesicles of mixed surfactants TDMAO/LiPFO.

Hörmann AF, Feoktystov A, Narayanan T, Gummel J, Gradzielski M. Hörmann AF, et al. J Chem Phys. 2023 Jun 7;158(21):214901. doi: 10.1063/5.0150223. J Chem Phys. 2023. PMID: 37260010

4

Effects of Side Chain and Peptide Bond Modifications on the Targeting Properties of Stabilized Minigastrin Analogs.

Zavvar TS, Hörmann AA, Klingler M, Summer D, Rangger C, Desrues L, Castel H, Gandolfo P, von Guggenberg E. Zavvar TS, et al. Among authors: hormann aa. Pharmaceuticals (Basel). 2023 Feb 13;16(2):278. doi: 10.3390/ph16020278. Pharmaceuticals (Basel). 2023. PMID: 37052226 Free PMC article.

5

Development of the ^99mTc-Labelled SST₂ Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study.

Novak D, Janota B, Hörmann AA, Sawicka A, Kroselj M, Hubalewska-Dydejczyk A, Fani M, Mikolajczak R, Kolenc P, Decristoforo C, Garnuszek P. Novak D, et al. Among authors: hormann aa. Pharmaceutics. 2023 Mar 9;15(3):885. doi: 10.3390/pharmaceutics15030885. Pharmaceutics. 2023. PMID: 36986746 Free PMC article.

6

Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of ¹⁷⁷Lu-Labeled Peptide Analogs Targeting CCK2R.

Hörmann AA, Klingler M, Rangger C, Mair C, Joosten L, Franssen GM, Laverman P, von Guggenberg E. Hörmann AA, et al. Pharmaceutics. 2023 Feb 28;15(3):796. doi: 10.3390/pharmaceutics15030796. Pharmaceutics. 2023. PMID: 36986657 Free PMC article.

7

Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling.

Wilding B, Scharn D, Böse D, Baum A, Santoro V, Chetta P, Schnitzer R, Botesteanu DA, Reiser C, Kornigg S, Knesl P, Hörmann A, Köferle A, Corcokovic M, Lieb S, Scholz G, Bruchhaus J, Spina M, Balla J, Peric-Simov B, Zimmer J, Mitzner S, Fett TN, Beran A, Lamarre L, Gerstberger T, Gerlach D, Bauer M, Bergner A, Schlattl A, Bader G, Treu M, Engelhardt H, Zahn S, Fuchs JE, Zuber J, Ettmayer P, Pearson M, Petronczki M, Kraut N, McConnell DB, Solca F, Neumüller RA. Wilding B, et al. Among authors: hormann a. Nat Cancer. 2022 Jul;3(7):821-836. doi: 10.1038/s43018-022-00412-y. Epub 2022 Jul 26. Nat Cancer. 2022. PMID: 35883003

8

Interrogation of cancer gene dependencies reveals paralog interactions of autosome and sex chromosome-encoded genes.

Köferle A, Schlattl A, Hörmann A, Thatikonda V, Popa A, Spreitzer F, Ravichandran MC, Supper V, Oberndorfer S, Puchner T, Wieshofer C, Corcokovic M, Reiser C, Wöhrle S, Popow J, Pearson M, Martinez J, Weitzer S, Mair B, Neumüller RA. Köferle A, et al. Among authors: hormann a. Cell Rep. 2022 Apr 12;39(2):110636. doi: 10.1016/j.celrep.2022.110636. Cell Rep. 2022. PMID: 35417719 Free article.

9

Automated Synthesis of ⁶⁸Ga-Labeled DOTA-MGS8 and Preclinical Characterization of Cholecystokinin-2 Receptor Targeting.

Hörmann AA, Plhak E, Klingler M, Rangger C, Pfister J, Schwach G, Kvaternik H, von Guggenberg E. Hörmann AA, et al. Molecules. 2022 Mar 21;27(6):2034. doi: 10.3390/molecules27062034. Molecules. 2022. PMID: 35335396 Free PMC article.

10

Development of methylated cobalt-alkyne complexes with selective cytotoxicity against COX-positive cancer cell lines.

Baecker D, Sagasser J, Karaman S, Hörmann AA, Gust R. Baecker D, et al. Among authors: hormann aa. Arch Pharm (Weinheim). 2022 Feb;355(2):e2100408. doi: 10.1002/ardp.202100408. Epub 2021 Dec 10. Arch Pharm (Weinheim). 2022. PMID: 34893997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page